Skip to content

Clinical trials

Endometrial Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Belgium Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20071
20092
20102
20111
20121
20133
20141
20153
20165
20174
20184
20196
20202
20218
20222
20236
20245
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting19
Active, not recruiting11
Unknown status6
Terminated3
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC7
AstraZeneca5
Merck Sharp & Dohme LLC5
Eli Lilly and Company3
Genmab3
Incyte Corporation3
Karyopharm Therapeutics Inc3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Daiichi Sankyo2
Exelixis2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms73
Ovarian Neoplasms26
Uterine Cervical Neoplasms17
Carcinoma, Non-Small-Cell Lung10
Colorectal Neoplasms10
Neoplasm Metastasis9
Neoplasms9
Breast Neoplasms8
Pancreatic Neoplasms7
Fallopian Tube Neoplasms6

Trials

Showing 26 to 50 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.